You are here:

Emtricitabine 200 mg hard capsules (Emtriva®)

Advice

Following a resubmission

Emtricitabine (Emtriva®) is accepted for use within NHS Scotland for the treatment of HIV-1 infected adults in combination with other antiretroviral agents. It should be prescribed only by HIV specialists.

This indication is based on studies in treatment-naïve patients and treatment-experienced patients with stable virological control in whom, as part of antiretroviral therapy (ART) regimens, it has shown virological responses comparable with other ART. There is no experience of use in patients who are failing their current regimen or who have failed multiple regimens.

Drug Details

Drug Name: Emtricitabine 200 mg hard capsules (Emtriva®)
SMC Drug ID: 105/04
Manufacturer: Gilead Sciences Ltd
Indication: HIV-1 infected adults in combination with other antiretroviral agents
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Resubmission
Status: Accepted
Date Advice Published: 13 February 2006

Archived Advice

Full submission 12 July 2004

Back